Vol 13, No 2 (February 29, 2024): Translational Lung Cancer Research

Editorial Commentary

The sooner, the better: early clearance of plasma circulating tumor DNA in patients with advanced KRAS G12C mutant non-small cell lung cancer
Miguel García-Pardo, Pilar Garrido
Translational Lung Cancer Research  
2024;
13
(2)
:215-219
.
What the future holds: BBT-176, beyond third-generation EGFR tyrosine kinase inhibitors
Carmelo Laface, Palma Fedele
Translational Lung Cancer Research  
2024;
13
(2)
:220-222
.
Determinants of Aurora kinase B inhibitor sensitivity in small cell lung cancer
Lei Duan, Carl G. Maki
Translational Lung Cancer Research  
2024;
13
(2)
:223-228
.
Dual immuno-oncology agents as neoadjuvant therapy for patients with resectable non-small cell lung cancer
Hiroyuki Adachi, Hiroyuki Ito, Takuya Nagashima, Tetsuya Isaka, Aya Saito
Translational Lung Cancer Research  
2024;
13
(2)
:229-235
.
High-resolution genomic configuration of FGFR rearrangements dictates the therapeutic vulnerability of squamous cell lung cancers
Sook-Hee Hong, Tae-Min Kim
Translational Lung Cancer Research  
2024;
13
(2)
:236-239
.

Original Article

“We need to work towards it, whatever it takes.”—participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders
Rachael Helen Dodd, Ashleigh Rebecca Sharman, Mei Ling Yap, Emily Stone, Henry Marshall, Joel Rhee, Sue McCullough, Nicole Marion Rankin
Translational Lung Cancer Research  
2024;
13
(2)
:240-255
.
The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacity
Runze Li, Zhifei Li, Zhenlin Yang, Bin Qiu, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He
Translational Lung Cancer Research  
2024;
13
(2)
:256-268
.
Intracranial response pattern, tolerability and biomarkers associated with brain metastases in non-small cell lung cancer treated by tislelizumab plus chemotherapy
Shen Zhao, Wei Jiang, Nong Yang, Li Liu, Yan Yu, Qiming Wang, Yuanyuan Zhao, Yunpeng Yang, Shuxiang Ma, Qitao Yu, Li Zhang, Yan Huang
Translational Lung Cancer Research  
2024;
13
(2)
:269-279
.
Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analyses
Sehhoon Park, Jun-Kyu Kang, Naeun Lee, Se-Hoon Lee, Hwang-Phill Kim, Su Yeon Kim, Tae-You Kim, Hyemin Kim, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park
Translational Lung Cancer Research  
2024;
13
(2)
:280-291
.
Systemic immune index predicts tumor-infiltrating lymphocyte intensity and immunotherapy response in small cell lung cancer
Chaoqiang Deng, Jiatao Liao, Zichen Fu, Fangqiu Fu, Di Li, Yuan Li, Jialei Wang, Haiquan Chen, Yang Zhang
Translational Lung Cancer Research  
2024;
13
(2)
:292-306
.
Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?
Mau Ern Poh, Chee Shee Chai, Chong Kin Liam, Gwo Fuang Ho, Yong Kek Pang, Harissa Husainy Hasbullah, Lye Mun Tho, Ibtisam Muhamad Nor, Kean Fatt Ho, Muthukkumaran Thiagarajan, Azlina Samsudin, Azza Omar, Choo Khoon Ong, Sing Yang Soon, Sin Nee Tan, Soon Hin How
Translational Lung Cancer Research  
2024;
13
(2)
:307-320
.
HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors
Meejeong Kim, Hyun-min Ju, Ji-young Song, Josephina Sampson, Richard Bayliss, Jene Choi
Translational Lung Cancer Research  
2024;
13
(2)
:321-333
.
Outcomes following minimally invasive approaches vs. open extended lobectomy for non-small cell lung cancer: a propensity-matched analysis of the National Cancer Database
Tangbing Chen, Ernest G. Chan, Binhao Huang, Luca Bertolaccini, Hiran C. Fernando, Panagiotis T. Tasoudis, Natalia Motas, Arjun Pennathur, Wentao Fang, Jie Zhang
Translational Lung Cancer Research  
2024;
13
(2)
:334-344
.
PD-L1 mRNA derived from tumor-educated platelets as a potential immunotherapy biomarker in non-small cell lung cancer
Zhihuang Hu, Na Wang, Yao Zhang, Daoyun Zhang, Si Sun, Hui Yu, Ying Lin, Xinmin Zhao, Huijie Wang, Xianghua Wu, Yoshinobu Ichiki, Satoshi Watanabe, Ziying Gong, Jianhua Chang, Jialei Wang
Translational Lung Cancer Research  
2024;
13
(2)
:345-354
.

Brief Report

Fibre-based fluorescence-lifetime imaging microscopy: a real-time biopsy guidance tool for suspected lung cancer
Susan Fernandes, Elvira Williams, Neil Finlayson, Hazel Stewart, Catharine Dhaliwal, David A. Dorward, William A. Wallace, Ahsan R. Akram, James Stone, Kevin Dhaliwal, Gareth O. S. Williams
Translational Lung Cancer Research  
2024;
13
(2)
:355-361
.

Review Article

Survivin in lung cancer: a potential target for therapy and prevention—a narrative review
Akhil Goud Pachimatla, Robert Fenstermaker, Michael Ciesielski, Sai Yendamuri
Translational Lung Cancer Research  
2024;
13
(2)
:362-374
.
Clinical translation for targeting DNA damage repair in non-small cell lung cancer: a review
Xinru Mao, Nung Kion Lee, Shaban Eljali Saad, Isabel Lim Fong
Translational Lung Cancer Research  
2024;
13
(2)
:375-397
.
Immunotherapy for advanced non-small cell lung cancer with negative programmed death-ligand 1 expression: a literature review
Yibing Bai, Wenyu Yang, Lukas Käsmann, Michael J. Sorich, Haitao Tao, Yi Hu
Translational Lung Cancer Research  
2024;
13
(2)
:398-422
.

Case Report: iMDT Corner

Single-port video-assisted thoracoscopic sleeve lobectomy after neoadjuvant immunochemotherapy: a case report
Hao Chen, Jiarong Zhang, Antonio Rossi, Duilio Divisi, Chun Chen, Bin Zheng
Translational Lung Cancer Research  
2024;
13
(2)
:423-433
.

Case Report

Osimertinib in uncommon EGFR exon 21 L861R and EGFR exon 18 deletion-insertion mutant non-small cell lung cancer—case report
Yang Wang, Pranav Dorwal, Suraindra Rajadurai, Surein Arulananda
Translational Lung Cancer Research  
2024;
13
(2)
:434-442
.
Imaging performance of thoracic SMARCA4-deficient undifferentiated tumor: a case report and literature review
Di Yang, Yong Wang
Translational Lung Cancer Research  
2024;
13
(2)
:443-452
.